Tokyo Tape
Sign in
← Ain Holdings

Quarterly report · Q2

9627.TEDINET S100PT4M
Period2022-05-01 → 2022-10-31
Filed2022-12-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥171.2bn2022-05-01 → 2022-10-31Cons.Net sales
Revenue¥316.2bn2021-05-01 → 2022-04-30Cons.Net sales (5-year summary)
Revenue¥153.0bn2021-05-01 → 2021-10-31Cons.Net sales
Operating income¥6.8bn2022-05-01 → 2022-10-31Cons.Operating income
Operating income¥5.8bn2021-05-01 → 2021-10-31Cons.Operating income
Ordinary income¥7.3bn2022-05-01 → 2022-10-31Cons.Ordinary income
Ordinary income¥16.0bn2021-05-01 → 2022-04-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥6.1bn2021-05-01 → 2021-10-31Cons.Ordinary income
Profit before tax¥7.2bn2022-05-01 → 2022-10-31Cons.Income before income taxes
Profit before tax¥6.1bn2021-05-01 → 2021-10-31Cons.Income before income taxes
Net income (owners)¥3.8bn2022-05-01 → 2022-10-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥7.1bn2021-05-01 → 2022-04-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.3bn2021-05-01 → 2021-10-31Cons.Profit loss attributable to owners of parent
Net income¥3.8bn2022-05-01 → 2022-10-31Cons.Profit loss
Net income¥3.3bn2021-05-01 → 2021-10-31Cons.Profit loss
Total assets¥231.1bnat 2022-10-31Cons.Assets
Total assets¥212.5bnat 2022-04-30Cons.Assets
Total assets¥210.4bnat 2021-10-31Cons.Total assets (5-year summary)
Total liabilities¥110.3bnat 2022-10-31Cons.Liabilities
Total liabilities¥93.5bnat 2022-04-30Cons.Liabilities
Net assets / equity¥120.9bnat 2022-10-31Cons.Net assets
Net assets / equity¥119.0bnat 2022-04-30Cons.Net assets
Net assets / equity¥115.8bnat 2021-10-31Cons.Net assets (5-year summary)
Cash and deposits¥46.7bnat 2022-10-31Cons.Cash and deposits
Cash and deposits¥59.7bnat 2022-04-30Cons.Cash and deposits
Cash & equivalents¥43.5bnat 2022-10-31Cons.Cash and cash equivalents
Cash & equivalents¥59.5bnat 2022-04-30Cons.Cash and cash equivalents
Cash & equivalents¥58.4bnat 2021-10-31Cons.Cash and cash equivalents
Cash & equivalents¥55.0bnat 2021-04-30dCons.Cash and cash equivalents
Operating cash flow¥8.5bn2022-05-01 → 2022-10-31Cons.Net cash provided by used in operating activities
Operating cash flow¥26.2bn2021-05-01 → 2022-04-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥17.3bn2021-05-01 → 2021-10-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥18.6bn2022-05-01 → 2022-10-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥13.9bn2021-05-01 → 2022-04-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥8.3bn2021-05-01 → 2021-10-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥5.8bn2022-05-01 → 2022-10-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥7.8bn2021-05-01 → 2022-04-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥5.6bn2021-05-01 → 2021-10-31Cons.Net cash provided by used in financing activities
EPS (basic)¥108.32022-05-01 → 2022-10-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥59.772022-08-01 → 2022-10-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥201.472021-05-01 → 2022-04-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥94.682021-05-01 → 2021-10-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥57.62021-08-01 → 2021-10-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio52.3%at 2022-10-31Cons.Equity to asset ratio (5-year summary)
Equity ratio56.0%at 2022-04-30Cons.Equity to asset ratio (5-year summary)
Equity ratio55.0%at 2021-10-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 34
SegmentItemPeriodValue
Otherother segmentsrevenue2022-05-01 → 2022-10-31¥5.8bn
Otherother segmentsrevenue external2022-05-01 → 2022-10-31¥5.8bn
Otherother segmentsrevenue intersegment2022-05-01 → 2022-10-31¥31m
Otherother segmentssegment ordinary income2022-05-01 → 2022-10-31−¥18m
Reconciling Itemsreconcilingrevenue2022-05-01 → 2022-10-31−¥31m
Reconciling Itemsreconcilingrevenue intersegment2022-05-01 → 2022-10-31−¥31m
Reconciling Itemsreconcilingsegment ordinary income2022-05-01 → 2022-10-31−¥3.8bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue2022-05-01 → 2022-10-31¥153.2bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2022-05-01 → 2022-10-31¥153.2bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2022-05-01 → 2022-10-31¥10.8bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2022-05-01 → 2022-10-31¥12.2bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2022-05-01 → 2022-10-31¥12.2bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2022-05-01 → 2022-10-31¥349m
—segment totalrevenue2022-05-01 → 2022-10-31¥171.2bn
—segment totalrevenue external2022-05-01 → 2022-10-31¥171.2bn
—segment totalrevenue intersegment2022-05-01 → 2022-10-31¥31m
—segment totalsegment ordinary income2022-05-01 → 2022-10-31¥11.1bn
Otherother segmentsrevenue2021-05-01 → 2021-10-31¥6.3bn
Otherother segmentsrevenue external2021-05-01 → 2021-10-31¥6.3bn
Otherother segmentsrevenue intersegment2021-05-01 → 2021-10-31¥47m
Otherother segmentssegment ordinary income2021-05-01 → 2021-10-31−¥121m
Reconciling Itemsreconcilingrevenue2021-05-01 → 2021-10-31−¥47m
Reconciling Itemsreconcilingrevenue intersegment2021-05-01 → 2021-10-31−¥47m
Reconciling Itemsreconcilingsegment ordinary income2021-05-01 → 2021-10-31−¥3.1bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue2021-05-01 → 2021-10-31¥136.9bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2021-05-01 → 2021-10-31¥136.9bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2021-05-01 → 2021-10-31¥10.5bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2021-05-01 → 2021-10-31¥9.8bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2021-05-01 → 2021-10-31¥9.8bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2021-05-01 → 2021-10-31−¥1.1bn
—segment totalrevenue2021-05-01 → 2021-10-31¥153.0bn
—segment totalrevenue external2021-05-01 → 2021-10-31¥153.0bn
—segment totalrevenue intersegment2021-05-01 → 2021-10-31¥47m
—segment totalsegment ordinary income2021-05-01 → 2021-10-31¥9.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 565
ItemContextValueUnit
Depreciation sgaPrior1YTDDuration590000000JPY
Depreciation sgaCurrentYTDDuration717000000JPY
Amortization of goodwill sgaPrior1YTDDuration2012000000JPY
Amortization of goodwill sgaCurrentYTDDuration2070000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E04896-000DispensingPharmacyReportableSegmentsMember136905000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember9816000000JPY
Revenues from external customersPrior1YTDDuration_OtherReportableSegmentsMember6250000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember152972000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration152972000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E04896-000DispensingPharmacyReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_OtherReportableSegmentsMember47000000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember47000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-47000000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E04896-000DispensingPharmacyReportableSegmentsMember136905000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember9816000000JPY
Net salesPrior1YTDDuration_OtherReportableSegmentsMember6297000000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember153019000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-47000000JPY
Net salesPrior1YTDDuration152972000000JPY
Ordinary incomePrior1YTDDuration_jpcrp040300-q2r_E04896-000DispensingPharmacyReportableSegmentsMember10491000000JPY
Ordinary incomePrior1YTDDuration_jpcrp040300-q2r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember-1125000000JPY
Ordinary incomePrior1YTDDuration_OtherReportableSegmentsMember-121000000JPY
Ordinary incomePrior1YTDDuration_ReportableSegmentsMember9244000000JPY
Ordinary incomePrior1YTDDuration_ReconcilingItemsMember-3117000000JPY
Ordinary incomePrior1YTDDuration6127000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E04896-000DispensingPharmacyReportableSegmentsMember153248000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember12205000000JPY
Revenues from external customersCurrentYTDDuration_OtherReportableSegmentsMember5750000000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember171204000000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration171204000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E04896-000DispensingPharmacyReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_OtherReportableSegmentsMember31000000JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember31000000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-31000000JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E04896-000DispensingPharmacyReportableSegmentsMember153248000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember12205000000JPY
Net salesCurrentYTDDuration_OtherReportableSegmentsMember5781000000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember171235000000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-31000000JPY
Net salesCurrentYTDDuration171204000000JPY
Ordinary incomeCurrentYTDDuration_jpcrp040300-q2r_E04896-000DispensingPharmacyReportableSegmentsMember10769000000JPY
Ordinary incomeCurrentYTDDuration_jpcrp040300-q2r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember349000000JPY
Ordinary incomeCurrentYTDDuration_OtherReportableSegmentsMember-18000000JPY
Ordinary incomeCurrentYTDDuration_ReportableSegmentsMember11099000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-04-30pass rounding
balance sheet identityconsolidated 2022-10-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-04-30pass
statement vs summary · net assetsconsolidated 2022-10-31pass
statement vs summary · net income attributable to parentconsolidated 2021-05-01/2021-10-31pass
statement vs summary · net income attributable to parentconsolidated 2022-05-01/2022-10-31pass
statement vs summary · operating cash flowconsolidated 2021-05-01/2021-10-31pass
statement vs summary · operating cash flowconsolidated 2022-05-01/2022-10-31pass
statement vs summary · revenueconsolidated 2021-05-01/2021-10-31pass
statement vs summary · revenueconsolidated 2022-05-01/2022-10-31pass
statement vs summary · total assetsconsolidated 2022-04-30pass
statement vs summary · total assetsconsolidated 2022-10-31pass